Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 2 , Pages 94-96, March 2006

Prognostic factors for first recurrence in patients with retroperitoneal sarcoma

  • Christophe Avancès, M.D.

      Affiliations

    • Department of Urology, Centre Hospitalier Universitaire, Nîmes, France
  • ,
  • Nicolas Mottet, M.D., Ph.D.

      Affiliations

    • Department of Urology, Clinique Mutualiste, Saint-Etienne, France
  • ,
  • Aba Mahatmat, M.D.

      Affiliations

    • Department of Biostatistics, Centre Hospitalier Universitaire, Nîmes, France
  • ,
  • Eliette Chapuis, M.D.

      Affiliations

    • Department of Pathology, Centre Hospitalier Universitaire, Nîmes, France
  • ,
  • Isabelle Serre, M.D.

      Affiliations

    • Department of Pathology, Centre Hospitalier Universitaire, Montpellier, France
  • ,
  • Stéphane Culine, M.D., Ph.D.

      Affiliations

    • Department of Medical Oncology, CRLC Val d’Aurelle, Montpellier, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-467613152; fax: +33-467613022

Received 3 January 2005; received in revised form 1 September 2005; accepted 2 September 2005.

Abstract 

Background

Retroperitoneal sarcomas are characterized by a high local recurrence rate despite optimal surgical treatment. The definition of prognostic factors for recurrence could help offer high-risk patients a closer follow-up and a multidisciplinary therapeutic approach.

Patients and Methods

A cohort of 40 patients treated for a primary retroperitoneal sarcoma was retrospectively analyzed. Median follow-up was 24 months. Patient (sex and age), tumor (maximal size, histologic type, tumor localization, and histologic grade), and treatment (complete vs. incomplete surgery) characteristics were included in univariate and multivariate prognostic factor analyses.

Results

After a median follow-up of 24 months (range 3−121), the overall recurrence rate was 65%. Median time between initial surgery and recurrence was 15 months (range 11.5−29.5). In univariate analysis, surgical positive margins (P = 0.011), bilateral tumors (P = 0.0034), nonliposarcoma histologic subtypes (P = 0.043), and a high histologic grade (P = 0.0072) were associated with an increased recurrence rate. All these factors except the histologic subtypes retained an independent prognostic value in the multivariate analysis. Death was strongly related to recurrence (P = 0.0033).

Conclusion

The optimal treatment of patients with primary retroperitoneal sarcoma should be based on radical surgery, with en bloc organ resection if necessary, to minimize the risk of positive margins. In high-risk patients, close follow-up is mandatory to offer optimal subsequent surgical procedures. The impact of a multidisciplinary therapeutic approach remains to be proved.

Keywords:  Retroperitoneal sarcoma , Prognostic factors , Complete excision , Surgery , Tumor grade , Multivariate analysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(05)00229-2

doi:10.1016/j.urolonc.2005.09.004

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 2 , Pages 94-96, March 2006